The Future Medicine Science Match (FMSM) is a flagship event with a focus on medical research, innovative ideas and concepts for the future of science, research and health care, taking place during the Berlin Science Week. EUHA is a network partner at this year’s conference and several EUHA colleagues will contribute by participating in panel discussions.
The Future Medicine Science Match (FMSM) is a conference brought forth by the cooperation between Tagesspiegel and the Berlin Institute of Health (BIH). It brings together 500 guests and up to 80 international speakers – renowned scientists, newcomers and political stakeholders – and is not only a platform for a dynamic exchange of ideas but also a meeting point for international experts in economics, politics, science and society. This year, EUHA is a network partner of the conference and will contribute to panel discussions.
The focus of this year’s conference lies on how an Ecosystem for Innovations in Cell and Gene Therapy can be developed and how can academia, business and society create an environment for innovations. The topic is very well aligned with EUHA’s strategic goal to drive the development of sustainable innovative therapies and is especially related to the EUCCAT (European Centre for Gene and Cellular Therapies) group.
In 2019 , EUHA started EUCCAT to facilitate the clinical use of academia-developed Advanced Therapy Medicinal Products (ATMPs) and leverage the potential of basic research conducted in Europe. The group brings together basic research groups, drug manufacturing facilities, clinical trial capacity, and implementation expertise and has initiated a decentralised cross-border clinical study of ATMPs within EUHA hospitals. The trial aims to pave the way towards the provision of safe, efficient, and equitable access to ATMPs and to avoid current hurdles that threaten the sustainability of such products within EU healthcare systems
The conference, which takes place on Thursday 9th of November, will feature several EUCCAT colleagues. Concretely, EUCCAT colleagues will be contributing to the session “Advanced Therapy Networks: Cooperation of Academia and Industry” (11:00 – 12:15 CET) , which will focus on how ATMPs are considered game changers to the medical treatment we know today.
The session will emphasise how novel collaborations are needed that go beyond a conventional distribution of tasks. EUCCAT experts are excellent candidates for sharing their experience from the intense collaboration among EUHA members, to develop academia-developed ATMPs based on the principles of fair rewards, cost-sharing and ethical pricing.
Colleagues that will contribute to the discussions are: